Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 69 Months Ended
Mar. 31, 2011
Mar. 31, 2012
Cash flows from operating activities:    
Net loss $ (22,543) $ (63,130)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 210 4,748
Acquired in-process research and development 20,706 20,706
Noncash interest   1,031
Noncash interest-related parties   286
Contribution of services by stockholder 10 130
Issuance of Common Stock to non-employee for services   121
Change in fair value of common stock warrant liability   234
Change in fair value of embedded conversion feature   831
Change in fair value of preferred stock warrant liability   1,407
Amortization of deferred financing costs   737
Depreciation expense 2 41
Changes in operating assets and liabilities:    
Other assets (28) (308)
Interest payable-related parties 18 19
Accounts payable and accrued expenses (159) 3,824
Net cash used in operating activities (1,784) (29,323)
Cash flows from investing activities:    
Purchase of computer equipment   (41)
Purchase of in-process research and development (3,809) (3,843)
Net cash used in investing activities (3,809) (3,884)
Cash flows from financing activities:    
Proceeds from PCP notes payable-related party   570
Payment of PCP notes payable-related party   (570)
Proceeds from notes payable-related parties   2,221
Proceeds from borrowings under line of credit   80
Payment of line of credit   (80)
Proceeds from senior convertible notes   7,570
Payment of debt issue costs   (737)
Payment of notes payable-related parties   (600)
Proceeds from issuance of Common Stock   198
Net cash provided by financing activities   50,942
(Decrease) Increase in cash and cash equivalents (5,593) 17,735
Cash and cash equivalents-beginning of period 14,862  
Cash and cash equivalents-end of period 9,269 17,735
Supplemental disclosure of cash flow information:    
Cash paid for interest   159
Supplemental disclosure of non-cash financing and investing activities:    
Issuance of Series B Convertible Preferred Stock for purchase of assets 16,114 16,114
Assumption of PCP note related to Asphelia Asset Purchase 750 750
Issuance of Series C Convertible Preferred Stock warrants   1,286
Issuance of Common Stock warrants related to the Series A Convertible Preferred Stock financing   621
Conversion of senior convertible notes into Series A Convertible Preferred Stock   8,601
Conversion of notes payable-related parties into Series A Convertible Preferred Stock   1,907
Issuance of Common Stock for Series A, B and C Convertible Preferred Stock   67,004
Series A Convertible Preferred Stock [Member]
    
Cash flows from financing activities:    
Proceeds from issuance of Convertible Preferred Stock   21,681
Payment of costs related to the issuance of Convertible Preferred Stock   (2,291)
Series C Convertible Preferred Stock [Member]
    
Cash flows from financing activities:    
Proceeds from issuance of Convertible Preferred Stock   25,784
Payment of costs related to the issuance of Convertible Preferred Stock   $ (2,884)